Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.6%)
Apogee Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-AI Biotechnology LLC(4.87%),Access Industries Holdings LLC(4.87%)等
Apogee Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.6%)
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G:超过5%持股股东披露文件-Wellington Management Group LLP(10.70%),Wellington Group Holdings LLP(10.70%)等
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股变动声明-高管 Henderson Jane
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股变动声明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4:持股变动声明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股变动声明-董事 JONES WILLIAM A JR
Apogee Therapeutics | 4:持股变动声明-董事 McKenna Mark C.
Apogee Therapeutics | 4:持股变动声明-董事 Bollinger Lisa
Apogee Therapeutics | 4:持股变动声明-董事 Fox Jennifer A.
Apogee Therapeutics | 4:持股变动声明-董事 Shah Nimish P
暂无数据
暂无数据